CNAT - Conatus Pharmaceuticals (CNAT) CEO Steve Mento on Q3 2018 Results - Earnings Call Transcript
Conatus Pharmaceuticals (CNAT)
Q3 2018 Earnings Conference Call
November 01, 2018, 04:30 PM ET
Executives
Alan Engbring - Executive Director of IR and Corporate Communications
Steve Mento - President and CEO
Keith Marshall - EVP, COO and CFO
Analysts
Yasmeen Rahimi - ROTH Capital Partners
Ed Arce - H. C. Wainwright & Co.
Jay Olson - Oppenheimer
Presentation
Operator
Welcome to the Conatus Pharmaceuticals Financial Results Conference Call. [Operator Instructions]
This call is being webcast live on the Investor Center of the Conatus website at conatuspharma.com. This call is property of Conatus Pharmaceuticals, and recordings,